drugset / Trial / NCT02066207

CKD-337 Drug Interaction Study

NCT02066207

Phase 1 Completed 30 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to evaluate a pharmacokinetic drug interaction between atorvastatin and fenofibrate in healthy subjects.

Timeline

Start
2014-03-18
Primary completion
2014-04-07
Completion
2014-05-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule
Subject Fenofibrate Small molecule